FDA issues new guidances to advance biosimilarsThe Food and Drug Administration said it expects to focus on preventing potentially anti-competitive practices for biosimilar drugs. National Hispanic Health Foundation launches National Hispanic Pharmacists AssociationWith support from public and private organizations, the National Hispanic Health Foundation is launching the National Hispanic Pharmacists Association. FDA gives Lupin's generic Eliquis tentative approval The FDA has given tentative clearance for Lupin's generic Eliquis, which had a market value of about $6.4 billion. Innovation's Phil Samples elected to AMSUS board Innovation's Phil Samples has been elected to the board of AMSUS, the Society of Federal Health Professionals. Walgreens unveils Missouri medication disposal kiosks The chain on Tuesday unveiled the first disposal kiosks at one of the 14 locations in the state that house them alongside Missouri Gov. Mike Parson.r Gilead Sciences names Daniel O’Day chairman and CEO Daniel O'Day is leaving Roche to serve as chairman and CEO of Gilead Sciences, effective March 1, 2019. Lupin introduces generic Rapaflo Lupin rolls out generic Rapaflo, which had a market value of about $198.5 million. Presidential historian Doris Kearns Goodwin to address NACDS Annual Meeting NACDS Annual Meeting attendees will glean insights from renowned presidential historian Doris Kearns Goodwin. HFAP unveils compounding pharmacy certification HFAP's compounding pharmacy certification program ensures high standards of quality. Sun Pharma gets FDA green light for generic Ganirelix The Food and Drug Administration has cleared Sun Pharma's generic Ganirelix, which had a market value of about $67 million, according to IQVIA data. First Previous 546 547 548 549 550 Next Last
